Spironolactone as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration Article

publication date

  • January 1, 2017

webpage

published in

keywords

  • Central serous chorioretinopathy
  • Eplerenone
  • Mineralocorticoid receptor antagonists
  • Neovascular age-related macular degeneration
  • Spironolactone

start page

  • 314

end page

  • 320

volume

  • 8

issue

  • 2